Edward Borkowski - May 10, 2021 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
EVP, Operations
Signature
/s/ Edward Borkowski
Stock symbol
TXMD
Transactions as of
May 10, 2021
Transactions value $
-$46,022
Form type
4
Date filed
5/12/2021, 08:39 PM
Next filing
Jul 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXMD Common Stock Options Exercise +104K 104K May 10, 2021 Direct F1
transaction TXMD Common Stock Sale -$46K -44.3K -42.76% $1.04 59.2K May 11, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Restricted Stock Units Options Exercise $0 -104K -33.33% $0.00 207K May 10, 2021 Common Stock 104K $0.00 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 10, 2021, the reporting person received 103,500 shares of issuer common stock in settlement of restricted stock units (RSUs), which vested on March 30, 2021.
F2 The reported securities represent shares of issuer common stock sold upon settlement to satisfy tax obligations.
F3 Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.
F4 The RSUs vest in three equal installments annually beginning March 30, 2021, becoming fully vested on March 30, 2023.